Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).
about
Lectin of Concanavalin A as an anti-hepatoma therapeutic agentDDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth controlViruses associated with human cancerMulti-OMICs and Genome Editing Perspectives on Liver Cancer Signaling NetworksHistorical review of the causes of cancerSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospectsMolecular genetics of hepatocellular neoplasia.Hepatitis B virus-induced oncogenesis.Prevention by Lamivudine of hepatocellular carcinoma in patients infected with hepatitis B virusMolecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in micePhosphatidylcholine alteration identified using MALDI imaging MS in HBV-infected mouse livers and virus-mediated regeneration defects.Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesisTumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytesThe miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cellsTissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinomaThe expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles.Molecular viral oncology of hepatocellular carcinoma.Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis.Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomasThe effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.Replication and gene expression of mutant hepatitis B virus in a transgenic mouse containing the complete viral genome with mutant s geneHepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma.Chronic hepatitis B in hepatocarcinogenesisIndividualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.Future of molecular profiling of human hepatocellular carcinoma.Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axisA pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers.
P2860
Q21284430-D6BC2291-E3CE-40CB-928B-71642E4AF2AEQ24296626-0D3B75A0-5CFA-49A8-B24F-5C57603FBC33Q24653900-1C93854F-E5FA-49D6-91A8-16F9721022ADQ26741086-9207717F-07C4-4B0D-AD83-FFFA5495F6E8Q26767036-678BA509-2693-46D5-9400-3002047CCD41Q26773251-50EECCA4-D591-4B9F-92A4-C1EAFB8F0D6CQ30391932-18EA5FAC-A21D-4F2A-9709-4A204DE123BDQ33661037-6839BF06-7024-4861-98C5-70F9D92E6203Q33680701-A165658D-0D2D-4B46-ADBB-EC078A9431F9Q33787553-C05A1F59-3351-4624-887D-FF1651C3EFCEQ33855761-2A549FEE-F4EB-4C6A-B3D4-4EB508B8FA74Q33855801-63287D5B-10A3-4BA4-BF6D-6F084A8957D1Q33866448-A08F0EF0-D99F-4A0B-8841-B1B404217466Q33918324-80B63913-5DFB-4B38-AEBD-347DA346F615Q34012962-7ECCBBD7-F007-4F2E-A2BD-241E2E5F7C1DQ34015546-AC781E39-8B4A-463E-BFD4-5B329ED3A543Q34068117-7CAC4B2C-B91A-4648-A8BB-1864108B9B06Q34308946-FBD65EAC-84CC-42F1-B420-EE611CCB4BC0Q34316643-57166670-0F99-4ADD-98B6-B4746274EEABQ34325518-9DDD13E0-6F86-402C-B97E-4F99B575BCC2Q34458054-01A6C663-3E29-43C2-A331-567D792D270CQ34510171-12CD682C-0CAF-40A2-A11C-595167490B06Q34512395-D2694602-C0B6-41EE-A60C-8C974A46147EQ34605140-6A2CAE4D-DC7A-42A1-8384-248704577C7CQ34621874-925B26AA-8DF3-45FD-89C4-F470D6CA86A0Q35161891-C5918A58-A1DC-4EAE-A7F1-0783094A75FBQ35196596-76B6E428-DC70-42A3-BFA2-B4E3019F0F59Q35548839-2C2ACE79-12BC-407E-A803-5447A680126CQ35598120-58C412CA-02A2-4AC6-B411-2A07779091EDQ35598151-D6FFC3BB-C52D-4E37-98DB-F31C4ECE9F33Q35864702-A9CE1644-FDBD-4352-B107-EDC56742AA14Q35904190-78D7B50E-732B-4316-9740-533EBF1402E2Q36178105-DE3FDCE8-BDB3-4C8A-B2CA-FA491DFFDD79Q36281598-D0988A2D-7FC9-4D73-B037-B91C5E1D0E62Q36419017-FC13164F-FFFD-468F-8FC7-F4226D7E3E0EQ36557635-2E8C7CB8-08E5-4CD4-8BE3-EA3D6F9E0326Q36699256-9B5BF961-4171-4315-8B98-506A20AC483CQ36895812-1834D231-8637-4792-A139-031524FFB856Q37172987-82DBAD4F-B9FA-4A24-BA00-A468291A4F27Q37371049-642B6ED3-97D8-435F-AB0B-DBF9731ABF89
P2860
Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular bases for the develo ...... epatocellular carcinoma (HCC).
@ast
Molecular bases for the develo ...... epatocellular carcinoma (HCC).
@en
type
label
Molecular bases for the develo ...... epatocellular carcinoma (HCC).
@ast
Molecular bases for the develo ...... epatocellular carcinoma (HCC).
@en
prefLabel
Molecular bases for the develo ...... epatocellular carcinoma (HCC).
@ast
Molecular bases for the develo ...... epatocellular carcinoma (HCC).
@en
P356
P1476
Molecular bases for the develo ...... hepatocellular carcinoma (HCC)
@en
P2093
P304
P356
10.1006/SCBI.2000.0321
P577
2000-06-01T00:00:00Z